SEC Form 4 · accession 0001123292-16-001527
IMMUNE DESIGN CORP. · IMDZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Svennilson
Director
Period of report
Jan 4, 2016
Accepted (ET)
Jan 6, 2016 · 7:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001437786
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $19.39 | Jan 4, 2016 | A | 9,300 | A | — | Jan 4, 2026 | Common Stock | 9,300 | 9,300 | D |
Explanation of responses
- F1The shares underlying the option will become fully vested on January 4, 2017, subject to the Reporting Person's continuous service through such date.